Image 01 Image 03

Wuhan Coronavirus Tag

AstraZeneca announced Monday morning its COVID-19 vaccine, AZD1222, given in the United Kingdom and Brazil showed 90% effectiveness in preventing the virus after half a dose and then a full dose one month later. It is only 62% effective if given two full doses a month apart. The trial had 23,000 volunteers.